Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | AmeriHealth | Photodynamic Therapy (PDT) Using Porfimer Sodium (Photofrin)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-030 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Photodynamic Therapy (PDT) Using Levulan Kerastick or Ameluz (Aminolevulinic Acid HCl [ALA])PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-056 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Pharmacogenetics and Metabolite Monitoring for Using Azathioprine (AZA)/6-Mercaptopurine (6-MP) TherapyPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA06-014E-6049C57577 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (Phesgo)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-129 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Pertuzumab (Perjeta) and related biosimilar pertuzumab-dpzb (Poherdy)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-063 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Personalized Vaccines (e.g., Provenge)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-053 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Peroral Endoscopic Myotomy (POEM) ProceduresPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-117A-AC35BDE7DD | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Percutaneous Transluminal Angioplasty (PTA) Concurrent with or without Stenting and Extracranial- Intracranial (EC-IC) Arterial Bypass SurgeryPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-056 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Percutaneous Left Atrial Appendage (LAA) Closure for Non-Valvular Atrial Fibrillation (NVAF)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-013 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Percutaneous Intradiscal Annuloplasty (IDET/PIRFT)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-025 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Percutaneous Image-Guided Lumbar Decompression (PILD) for Spinal StenosisPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-097 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Percutaneous Electrical Nerve Stimulation (PENS) and Percutaneous Neuromodulation Therapy (PNT)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-064 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Percutaneous DiscectomyPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-096 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Percutaneous Coronary Intervention, Coronary Angiography, and Arterial UltrasoundPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-113N-21C2C55945 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Penpulimab-kcqxPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-186 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Pemetrexed (Pemfexy)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-047 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Pembrolizumab and berahyaluronidase alfa-pmph (KEYTRUDA QLEX)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-189A-CA24F3693A | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Pembrolizumab (Keytruda)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-121F-0B1ADFE369 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Pegloticase (Krystexxa)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-060 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | patisiran (Onpattro) and vutrisiran (Amvuttra)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-100 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Patient LiftsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-031 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Panniculectomy, Abdominoplasty, Abdominal Lipectomy, and Other Excisions of Redundant SkinPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-073 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Pain Management of Peripheral Nerves by InjectionPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-047 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)/(Abraxane for Injectable Suspension)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-049 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Outpatient Physical Medicine and Rehabilitation Services- Physical Therapy (PT) and Occupational Therapy (OT)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA10-003J-D11141A12A | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Otoplasty or Non-Surgical External Ear MoldingPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-058A-E49D2A7377 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Ostomy SuppliesPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-014 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Orthopedic FootwearPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-012 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Orthognathic SurgeryPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-083A-CB7287558D | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Omalizumab (Xolair) and related biosimilarsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-025 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | olipudase alfa-rpcp (Xenpozyme)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-154 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Off-label Coverage for Prescription Drugs and/or BiologicsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-012 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Octreotide Acetate (Sandostatin LAR Depot)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-065 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Ocrelizumab (Ocrevus) and Ocrelizumab and Hyaluronidase-ocsq (Ocrevus Zunovo)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-088E-34BF4BA987 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Nusinersen (Spinraza)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-086D-54F9058120 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | NucleoplastyPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-101 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Not Medically Necessary Services and Obsolete or Unreliable Diagnostic TestsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA00-001 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Non-Surgical Spinal Decompression TherapyPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA11-021 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Non-Spinal Osteogenic Stimulators (Electrical and Ultrasonic)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-018D-CF394E4F91 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Noninvasive Techniques for the Evaluation and Monitoring of Individuals with Chronic Liver DiseasePayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA06-024 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Nonemergent Inpatient Video Electroencephalogram (EEG) Monitoring and Ambulatory EEG Monitoring in the HomePayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-053 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Nogapendekin alfa inbakicept-pmln (Anktiva)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-175 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Nivolumab and relatlimab-rmbw (Opdualag) for intravenous usePayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-152 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Nivolumab (Opdivo), Nivolumab and Hyaluronidase-nvhy (Opdivo Qvantig)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-120G-E40D29927E | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Nipocalimab-aahu (Imaavy)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA08-187 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Never Events and Preventable Serious Adverse EventsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA00-039 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Neuropsychological Testing for Neurologically Based ConditionsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA07-038K-1A6082FE77 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Neuromuscular Electrical Stimulators (NMES) and Functional Electrical Stimulators (FES)PayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-058 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Nerve Fiber Density TestingPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA06-023 | New policy |
|---|
| Aug 2, 2026 | AmeriHealth | Negative Pressure Wound Therapy SystemsPayerPolicy · AMERIHEALTH-MEDICARE-ADVANTAGE-MA05-008 | New policy |
|---|